Q1 INTERIM REPORT JULY – SEPT 2026
Cancer Therapy and Novel treatments of bacterial infections
“ We have reached major goals in the fields of Cancer Therapy and Novel Anti-infectives, two of the major causes of disease. Our goal is to make the new therapies available to patients through suitable commercial partnerships. Reaching Phase III studies has been a long-term goal and we are there. We also have a strong pipeline of drug candidates in our portfolio to support the commercialization of innovations made by scientists at Lund University into the clinic”, comments Catharina Svanborg, Chairman.
“ We have